{"name":"Bio Products Laboratory","slug":"bio-products-laboratory","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"Coagadex","genericName":"Coagadex","slug":"coagadex","indication":"Other","status":"marketed"},{"name":"Optivate","genericName":"Optivate","slug":"optivate","indication":"Other","status":"discontinued"},{"name":"Gammaplex","genericName":"Gammaplex","slug":"gammaplex","indication":"Other","status":"marketed"},{"name":"Human Coagulation FACTOR X","genericName":"Human Coagulation FACTOR X","slug":"human-coagulation-factor-x","indication":"Other","status":"marketed"},{"name":"Subgam","genericName":"Subgam","slug":"subgam","indication":"Other","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"HyperRAB","genericName":"HyperRAB","slug":"hyperrab","indication":"Post-exposure prophylaxis of rabies in non-immunized individuals following potential rabies exposure","status":"marketed"},{"name":"Gammaplex 10","genericName":"Gammaplex 10","slug":"gammaplex-10","indication":"Primary immunodeficiency disorders","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Gammaplex (5%)","genericName":"Gammaplex (5%)","slug":"gammaplex-5","indication":"Primary immunodeficiency disorders","status":"marketed"}]}],"pipeline":[{"name":"HyperRAB","genericName":"HyperRAB","slug":"hyperrab","phase":"marketed","mechanism":"HyperRAB is a rabies immunoglobulin (human) that provides passive immunity by supplying antibodies against rabies virus.","indications":["Post-exposure prophylaxis of rabies in non-immunized individuals following potential rabies exposure"],"catalyst":""},{"name":"Coagadex","genericName":"Coagadex","slug":"coagadex","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Optivate","genericName":"Optivate","slug":"optivate","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gammaplex","genericName":"Gammaplex","slug":"gammaplex","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Gammaplex (5%)","genericName":"Gammaplex (5%)","slug":"gammaplex-5","phase":"marketed","mechanism":"Gammaplex is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to boost immune function.","indications":["Primary immunodeficiency disorders","Secondary immunodeficiency (e.g., chronic lymphocytic leukemia, HIV)","Idiopathic thrombocytopenic purpura (ITP)","Chronic inflammatory demyelinating polyneuropathy (CIDP)","Multifocal motor neuropathy"],"catalyst":""},{"name":"Gammaplex 10","genericName":"Gammaplex 10","slug":"gammaplex-10","phase":"phase_3","mechanism":"Gammaplex 10 is an intravenous immunoglobulin (IVIG) preparation that provides passive immunity by delivering pooled human antibodies to modulate immune function and replace deficient immunoglobulins.","indications":["Primary immunodeficiency disorders","Secondary immunodeficiency in hematologic malignancies","Autoimmune and inflammatory conditions (e.g., immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy)"],"catalyst":""},{"name":"Human Coagulation FACTOR X","genericName":"Human Coagulation FACTOR X","slug":"human-coagulation-factor-x","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Subgam","genericName":"Subgam","slug":"subgam","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQRFVzalEteDRNWWE3M3JTWFlacURvX1JQSHBweGJqRXZZUjFzYktRUnlkMmFuNzMtZDV6M1k1Rm9jV20ydFUwNksybHNGTG81WVlIaWRtMF90TlpsTURvOXE3YXRKVzE2bFdVcEJIdS02NWdFeWJRQkV5VUg4N0VRR3ZKZFBrYUV5b0xEaGstNVFwUkR5U0Flb3dFcS0?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Trends in Growth, Segment Analysis, and Competitive Approaches Influencing the Albumin Market - openPR.com","headline":"Trends in Growth, Segment Analysis, and Competitive Approaches Influencing the Albumin Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNV092UHBsbXg2elFDR0g3UlJmRDBBYklWZW5aSVlTRE5JTHdlS1YxalF1VktDamZTT2VjZThPeERxWkphcGswV2hEaXVwWDVjb21sUUxwLUdwZ3BPOElEcV9wdDFFQWJYcDNONkF3QUNBT2hPZ2swOFlZaUo3ZFdmQS1qckdyX1hNWnZmcXM0eXktcVRNQzA0WFlaNlFmaGdjMV9ZcEJXTTJKTFhVemZrTXFQS0xwVFVROTVJMVhsbEhsZkVvbF9CWU5yQXIyUjl6SDYyZDYzQ1VRR2JRTE1vaDNaLWJuN1NpSHI5SjFYTkJiQmdiZGQtRlFZa2J6OGlwcGQyT0FIY3hHSEdLQmphdw?oc=5","date":"2026-03-30","type":"pipeline","source":"Patient.info","summary":"Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18 - Patient.info","headline":"Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Inject","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9ZLXVqdHJfX2tkdVdRaUdseU9NZUI1czRvQ3lPdXI1eE85QUtEQVVwTm1NWTM3MllVSWltVEFLVFBmT284WDlwTlNaVzF5N2p6RU9BcWl6UG9GQ1puMEFJRjhn?oc=5","date":"2026-03-13","type":"pipeline","source":"globaltimes.cn","summary":"The New Era of the Pharmaceutical Industry in China - globaltimes.cn","headline":"The New Era of the Pharmaceutical Industry in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbFJFa19PTzBtRjRxaUlMWWJ2NjJIZ1Z3c3p2UndxektJOWVVelpoaVZ0dHdWeVdrN2p6OTVJVzF6RmlHaURMNDIzUFBVNTEzelBIOGdlTEFUalc0bW00eThkMXRNMFMtNFBkcTNXQnZfNkJQZDBhcTRtNWh1UXFqZ3B5bm1aVlYyZVVaMkNtVWJEcUNxYkkwUHlhakhxdjh5R3EyanU2R1RScWRyX1hlYll2dXFmei1Y?oc=5","date":"2025-11-17","type":"regulatory","source":"Clinical Leader","summary":"Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development - Clinical Leader","headline":"Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNUFRKX2QyWVU1LUFPZ1BPOHNjYXZfaHVVTGI4QkppRVJmcndVUXI5X2NjR1MzWFJYQXAzeE0zNXc3TzhjUVJBbHB4NTBQZFJOdTJLMGpkYS1pUEhMbDRMYjlmVWo3OERIUTZxNkhyTExFemwzbXcyUXBQWmdobWtJRDVnclpCT1g0Z0J6T1RuYUd4bGgzWFA0ZWEzYUVESzdKdFJxZmdIZ1YwNWJxQkdabENIRFNIUXowaDBYamxudGhGTlI2WlVWYUNkLWtXQnd6dHc?oc=5","date":"2025-10-07","type":"pipeline","source":"Biotech Newswire","summary":"Coriolis Pharma Accelerates U.S. Expansion with Strategic Appointments in North Carolina - Biotech Newswire","headline":"Coriolis Pharma Accelerates U.S. Expansion with Strategic Appointments in North Carolina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB6RDhtbElmc2hpd0VHOVJfQ1V4X2VCZnM1S25LRHE5aG5PbkNwZDdmTXR6MlFKbWNOTDFXSGwtOUlCUjJUeFFoY1BQbm9GZjdZZzYxMnVxTTY5aExPNXphOEVVYTVROU0?oc=5","date":"2025-07-16","type":"pipeline","source":"Market.us","summary":"Plasma Derived Medicine Market Growth Analysis | CAGR of 8.1% - Market.us","headline":"Plasma Derived Medicine Market Growth Analysis | CAGR of 8.1%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdE1fSnlQa2c5djgyTHNWd0xnQTlLTFZHS1pZWk9QQWZ4OE9tazBldUFwYlFZMmtHcVkxN1VkTDQ1N3dtanFGdHZsems2cGd0NDZIcktoTzY2aTNUdnFMTnBBVjdBcEVQMGlnNnZsNEVLdXV1T25yNWdyeVBVUllRaVI5VmZaMmpUUGhfMjNUSWtUTUhRUENoNXFNMFNNSXNORnZ6Tlc4aFEtd3pFQXc?oc=5","date":"2023-01-16","type":"pipeline","source":"European Pharmaceutical Review","summary":"Pharmaceutical microbiology: key developments 2022 - European Pharmaceutical Review","headline":"Pharmaceutical microbiology: key developments 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOdktfci1PRFhDLW5heXlydjBRemJhRUpIUEY3azNJcDNYcndIRGE2eFhiNFdmam5ZVEdzeHZSZlFpemlIN3VoV28xT0J5UWd0U3VIRU9uQ2hsVlN2UHNZZUgxUGRVRUFORHRVQ1RNQTl6Y3M1NmRBVTVsc0VIVEVGWFYyYklFeEtNcTI4V2hYMXRyMVJlMGJSd2xiV0g3ZjhUMXk0?oc=5","date":"2022-11-10","type":"pipeline","source":"The Business Journals","summary":"2022 Fast 50 Awards: No. 21 – Bio Products Laboratory - The Business Journals","headline":"2022 Fast 50 Awards: No. 21 – Bio Products Laboratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOTXpzcWdjTlI3OWRVN0Q4Z2xQV0F2OWRQZF9IX2EyZG1ZZmV0TUV3cXU5TUM5UmhKLUhtQW1fWGNPTmdyWWpBb1BFcmNaRVNQR1N1WDFSY01OUnRLXzE2SlVYbXlZb1ZUR3JfYXhncmZzdnNyV2JXa1dvcURKUVh2UEZ6NENnbjJsMXpFSVlhVjJXUDNJNVpNU243WWhMbWZ2QWFITjRR?oc=5","date":"2022-09-02","type":"pipeline","source":"pehub.com","summary":"Permira and Marcucci family complete purchase and combination of Kedrion and BPL - pehub.com","headline":"Permira and Marcucci family complete purchase and combination of Kedrion and BPL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxONWRnbXgzU1Z6Z0V3STZzRUkxWUVaLUxaczJGLTA4SEpSMHVQZ1BFNk9QWXI4SGk3VmVSQlFXc2FLbjJ5c0xDY0tLb05FdVJDV1hxbjBUaDE1Z1R2cjdSUDFibWlCY2duX1dmZC1oYm5iNTVXQ0VrcGQ3Z3BZSGE3UUZfUU5aYjBRNXgyMm9BY18tdlhOSFVaZFVzZmZKWHAxOUZJWVZLVjdCXzFhaUlWRjBROHdURnVlbjNWTjhxeTVlX09pRHhhWm5IUmh5b1ZCUUdnd3V5WkR0ejRVNnR0dXRhR2g4RndRdDdpMGdGU1JrTnpIZTZwdDlRdFhUenZlRE9uNWV5ZVlteTN0Yk1HV1h3?oc=5","date":"2022-09-01","type":"pipeline","source":"PR Newswire","summary":"Permira Funds and the Marcucci family complete investment in Kedrion and BPL and announce appointment of Ugo Di Francesco as CEO - PR Newswire","headline":"Permira Funds and the Marcucci family complete investment in Kedrion and BPL and announce appointment of Ugo Di Francesc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOU2FyQlRkQUJ1dDhnXzFUYlR4S0xoWXhDT3VUSGRUM3QwT0xCY3dZeGRpVjFFTV9JeEd6amFYUGhEVkEyeEswSVczeUFJSkJvc3VKVkgtQ3ZfVktISkc3cklkajRvNTlyUDBZdkNTNVoxZ3VpUXFoT1dPZ1pZNXFnMkNYcnYxSFUwaXdRbUtGY01WOV8xSlk3UkhwU05GLUNHYXdIX055aHpqV3I0RkFmS3kwYjh6c2k4c0pUUks5YzdRQQ?oc=5","date":"2020-10-19","type":"pipeline","source":"PharmiWeb.com","summary":"Bio Products Laboratory Receives Triangle Business Journal's Fast 50 Award - PharmiWeb.com","headline":"Bio Products Laboratory Receives Triangle Business Journal's Fast 50 Award","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOQWZpN0JIQzR1V3ZtWUItckJacEVzUFFDcFc3eXhKazY4aFplYUZ2ZURXNTVzYllRTUJWUkVrVGJ4RGNra1p3RVFRR1BtX1dEeUFLcFNRLVpTTl9PTmEyWURVa244OEZ0NFBmM081alJYTVIwYWQyMGNtUnljQ3ltenhVdGRmUVBfSldib0FUakpmSE10QWQ5Q0hDWFBtTS0zcWpfQndKdWhPcGk4akdoaFNvUlU0QUdzQVJ3aWtoNnBjckNsUllUeWRKQk9mWko4eFMzS2luREQ0QW1jb3hURDZxWkNUZmV2X3A4SFBNbUdjYjFMQUhtZ0R1TWg?oc=5","date":"2020-05-27","type":"pipeline","source":"BioSpace","summary":"Bio Products Laboratory Announces Launch of ALBUMINEX® 5% and ALBUMINEX® 25% With Supply Immediately Available in the United States - BioSpace","headline":"Bio Products Laboratory Announces Launch of ALBUMINEX® 5% and ALBUMINEX® 25% With Supply Immediately Available in the Un","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"marketed":5,"discontinued":1,"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}